Drug-induced renal injury in neonates: challenges in clinical practice and perspectives in drug development

References

• Askenazi DJ, Koralkar R, Hundley HE, et al. Fluid overload and mortality are associated with acute kidney injury in sick near-term/term neonate. Pediatr Nephrol. 2013 Apr;28(4):661–666.
   PubMed Web of Science ®Google Scholar
• Koralkar R, Ambalavanan N, Levitan EB, et al. Acute kidney injury reduces survival in very low birth weight infants. Pediatr Res. 2011 Apr;69(4):354–358.
   PubMed Web of Science ®Google Scholar
• Girardi A, Raschi E, Galletti S, et al. Drug-induced renal damage in preterm neonates: state of the art and methods for early detection. Drug Saf. 2015 Jun;38(6):535–551.
   PubMed Web of Science ®Google Scholar
• Luyckx VA, Brenner BM. Birth weight, malnutrition and kidney-associated outcomes – a global concern. Nat Rev Nephrol. 2015 Mar;11(3):135–149.
   PubMed Web of Science ®Google Scholar
• Raaijmakers A, Ortibus E, van Tienoven TP, et al. Neonatal creatinemia trends as biomarker of subsequent cognitive outcome in extremely low birth weight neonates. Early Hum Dev. 2015 Jun;91(6):367–372.
   PubMed Web of Science ®Google Scholar
• Akcan-Arikan A, Zappitelli M, Loftis LL, et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007 May;71(10):1028–1035.
   PubMed Web of Science ®Google Scholar
• Carmody JB, Swanson JR, Rhone ET, et al. Recognition and reporting of AKI in very low birth weight infants. Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2036–2043.
   PubMed Web of Science ®Google Scholar
• Jetton JG, Guillet R, Askenazi DJ, et al. Assessment of worldwide acute kidney injury epidemiology in neonates: design of a retrospective cohort study. Front Pediatr. 2016;4:68.
   PubMed Web of Science ®Google Scholar
• Bezerra CT, Vaz Cunha LC, Liborio AB. Defining reduced urine output in neonatal ICU: importance for mortality and acute kidney injury classification. Nephrol Dial Transplant. 2013 Apr;28(4):901–909.
   PubMed Web of Science ®Google Scholar
• Vieux R, Hascoet JM, Merdariu D, et al. Glomerular filtration rate reference values in very preterm infants. Pediatrics. 2010 May;125(5):e1186–e1192.
   PubMed Web of Science ®Google Scholar
• Bueva A, Guignard JP. Renal function in preterm neonates. Pediatr Res. 1994 Nov;36(5):572–577.
   PubMed Web of Science ®Google Scholar
• George I, Mekahli D, Rayyan M, et al. Postnatal trends in creatinemia and its covariates in extremely low birth weight (ELBW) neonates. Pediatr Nephrol. 2011 Oct;26(10):1843–1849.
   PubMed Web of Science ®Google Scholar
• Allegaert K, Pauwels S, Smits A, et al. Enzymatic isotope dilution mass spectrometry (IDMS) traceable serum creatinine is preferable over Jaffe in neonates and young infants. Clin Chem Lab Med. 2014 Jun;52(6):e107–e109.
   PubMed Web of Science ®Google Scholar
• Zhao W, Kaguelidou F, Biran V, et al. External evaluation of population pharmacokinetic models of vancomycin in neonates: the transferability of published models to different clinical settings. Br J Clin Pharmacol. 2013 Apr;75(4):1068–1080.
   PubMed Web of Science ®Google Scholar
• De Cock RF, Allegaert K, Schreuder MF, et al. Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance. Clin Pharmacokinet. 2012 Feb 1;51(2):105–117.
   PubMed Web of Science ®Google Scholar
• Allegaert K, Cossey V, Langhendries JP, et al. Effects of co-administration of ibuprofen-lysine on the pharmacokinetics of amikacin in preterm infants during the first days of life. Biol Neonate. 2004;86(3):207–211.
   PubMedGoogle Scholar
• Smits A, Kulo A, van den AJ, et al. The amikacin research program: a stepwise approach to validate dosing regimens in neonates. Expert Opin Drug Metab Toxicol. 2017 Feb;13(2):157–166.
   PubMed Web of Science ®Google Scholar
• De Cock RF, Allegaert K, Sherwin CM, et al. A neonatal amikacin covariate model can be used to predict ontogeny of other drugs eliminated through glomerular filtration in neonates. Pharm Res. 2014 Mar;31(3):754–767.
   PubMed Web of Science ®Google Scholar
• Allegaert K, Kuppens M, Mekahli D, et al. Creatinine reference values in ELBW infants: impact of quantification by Jaffe or enzymatic method. J Matern Fetal Neonatal Med. 2012 Sep;25(9):1678–1681.
   PubMed Web of Science ®Google Scholar
• Lemmens AS, Mekahli D, Devlieger R, et al. Population-specific serum creatinine centiles in neonates with posterior urethral valves already predict long-term renal outcome. J Matern Fetal Neonatal Med. 2015 Jun;28(9):1026–1031.
   PubMed Web of Science ®Google Scholar
• Smits A, Levtchenko E, van den Anker J, et al. Creatinine as biomarker for amikacin clearance in extreme low birth weight neonates: how to aim for a moving target? Clinical Pharmacology and Biopharmacy Meeting of October 3, 2012. Br J Clin Pharmacol. 2013;76(5):836.
   Web of Science ®Google Scholar
• Gupta C, Massaro AN, Ray PE. A new approach to define acute kidney injury in term newborns with hypoxic ischemic encephalopathy. Pediatr Nephrol. 2016 Jul;31(7):1167–1178.
   PubMed Web of Science ®Google Scholar
• Turner MA, Davis JM, McCune S, et al. The International Neonatal Consortium: collaborating to advance regulatory science for neonates. Pediatr Res. 2016 Oct;80(4):462–464.
   PubMed Web of Science ®Google Scholar
• Adeli K. Closing the gaps in pediatric reference intervals: an update on the CALIPER project. Clin Biochem. 2014 Jun;47(9):737–739.
   PubMed Web of Science ®Google Scholar
• Vieux R, Fresson J, Guillemin F, et al. Perinatal drug exposure and renal function in very preterm infants. Arch Dis Child Fetal Neonatal Ed. 2011 Jul;96(4):F290–F295.
   PubMed Web of Science ®Google Scholar
• Safina AI, Daminova MA, Abdullina GA. Acute kidney injury in neonatal intensive care: medicines involved. Int J Risk Saf Med. 2015;27(Suppl 1):S9–S10.
   PubMedGoogle Scholar
• Cataldi L, Leone R, Moretti U, et al. Potential risk factors for the development of acute renal failure in preterm newborn infants: a case-control study. Arch Dis Child Fetal Neonatal Ed. 2005 Nov;90(6):F514–F519.
   PubMed Web of Science ®Google Scholar
• Jetton JG, Askenazi DJ. Update on acute kidney injury in the neonate. Curr Opin Pediatr. 2012 Apr;24(2):191–196.
   PubMed Web of Science ®Google Scholar
• Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009 Mar;20(3):629–637.
   PubMed Web of Science ®Google Scholar
• Pottel H, Hoste L, Martens F. A simple height-independent equation for estimating glomerular filtration rate in children. Pediatr Nephrol. 2012 Jun;27(6):973–979.
   PubMed Web of Science ®Google Scholar
• Filler G, Guerrero-Kanan R, Varez-Elias AC. Assessment of glomerular filtration rate in the neonate: is creatinine the best tool? Curr Opin Pediatr. 2016 Apr;28(2):173–179.
   PubMed Web of Science ®Google Scholar
• Zwiers AJ, Cransberg K, de Rijke YB, et al. Reference ranges for serum beta-trace protein in neonates and children younger than 1 year of age. Clin Chem Lab Med. 2014 Dec;52(12):1815–1821.
   PubMed Web of Science ®Google Scholar
• Allegaert K, Mekahli D, van den AJ. Cystatin C in newborns: a promising renal biomarker in search for standardization and validation. J Matern Fetal Neonatal Med. 2015;28(15):1833–1838.
   PubMed Web of Science ®Google Scholar
• Abbink FC, Laarman CA, Braam KI, et al. Beta-trace protein is not superior to cystatin C for the estimation of GFR in patients receiving corticosteroids. Clin Biochem. 2008 Mar;41(4–5):299–305.
   PubMed Web of Science ®Google Scholar
• Saeidi B, Koralkar R, Griffin RL, et al. Impact of gestational age, sex, and postnatal age on urine biomarkers in premature neonates. Pediatr Nephrol. 2015 Nov;30(11):2037–2044.
   PubMed Web of Science ®Google Scholar
• Elmas AT, Tabel Y, Ipek S. Determination of reference values for urinary neutrophil gelatinase-associated lipocalin in premature infants. J Matern Fetal Neonatal Med. 2014 Jan;27(2):187–191.
   PubMed Web of Science ®Google Scholar
• Askenazi DJ, Montesanti A, Hunley H, et al. Urine biomarkers predict acute kidney injury and mortality in very low birth weight infants. J Pediatr. 2011 Dec;159(6):907–912.
   PubMed Web of Science ®Google Scholar
• Askenazi DJ, Koralkar R, Hundley HE, et al. Urine biomarkers predict acute kidney injury in newborns. J Pediatr. 2012 Aug;161(2):270–275.
   PubMed Web of Science ®Google Scholar
• Askenazi DJ, Koralkar R, Patil N, et al. Acute kidney injury urine biomarkers in very low-birth-weight infants. Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1527–1535.
   PubMed Web of Science ®Google Scholar
• Stojanovic VD, Barisic NA, Vuckovic NM, et al. Urinary kidney injury molecule-1 rapid test predicts acute kidney injury in extremely low-birth-weight neonates. Pediatr Res. 2015 Oct;78(4):430–435.
   PubMed Web of Science ®Google Scholar
• Sarafidis K, Tsepkentzi E, Diamanti E, et al. Urine neutrophil gelatinase-associated lipocalin to predict acute kidney injury in preterm neonates. Pilot Study Pediatr Nephrol. 2014 Feb;29(2):305–310.
   PubMed Web of Science ®Google Scholar
• Jansen D, Peters E, Heemskerk S, et al. Tubular injury biomarkers to detect gentamicin-induced acute kidney injury in the neonatal intensive care unit. Am J Perinatol. 2016 Jan;33(2):180–187.
   PubMed Web of Science ®Google Scholar
• McWilliam SJ, Antoine DJ, Sabbisetti V, et al. Mechanism-based urinary biomarkers to identify the potential for aminoglycoside-induced nephrotoxicity in premature neonates: a proof-of-concept study. Plos One. 2012;7(8):e43809.
   PubMed Web of Science ®Google Scholar
• Mehta RL, Awdishu L, Davenport A, et al. Phenotype standardization for drug-induced kidney disease. Kidney Int. 2015 Apr 8;88:226–234.
   PubMed Web of Science ®Google Scholar
• Atzori L, Antonucci R, Barberini L, et al. 1H NMR-based metabolomic analysis of urine from preterm and term neonates. Front Biosci (Elite Ed). 2011;3:1005–1012.
   PubMedGoogle Scholar
• Mercier K, McRitchie S, Pathmasiri W, et al. Preterm neonatal urinary renal developmental and acute kidney injury metabolomic profiling: an exploratory study. Pediatr Nephrol. 2017 Jan;32(1):151–161.
   PubMed Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993 Dec 3;75(5):843–854.
   PubMed Web of Science ®Google Scholar
• Ramachandran K, Saikumar J, Bijol V, et al. Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury. Clin Chem. 2013 Dec;59(12):1742–1752.
   PubMed Web of Science ®Google Scholar
• Weber JA, Baxter DH, Zhang S, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010 Nov;56(11):1733–1741.
   PubMed Web of Science ®Google Scholar
• Turchinovich A, Weiz L, Langheinz A, et al. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011 Sep 1;39(16):7223–7233.
   PubMed Web of Science ®Google Scholar
• Sun Y, Koo S, White N, et al. Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res. 2004;32(22):e188.
   PubMed Web of Science ®Google Scholar
• Drug Development Tools Qualification Programs. Biomarker Qualification Program. Food and Drug Administration (FDA). 2016; [cited 2016 Sep 23]. Available from: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugDevelopmentToolsQualificationProgram/ucm284076.htm
   Google Scholar
• Committee for Medicinal Products for Human Use (CHMP). Qualification of novel methodologies for medicine development. European Medicines Agency (EMA). 2016; [cited 2016 Sep 23]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000319.jsp&mid=WC0b01ac0580022bb0
   Google Scholar
• Committee for Medicinal Products for Human Use (CHMP). Qualification opinion ILSI/HESI submission of novel renal biomarkers for toxicity. European Medicines Agency (EMA). 2010 Oct 21; [cited 2016 Sep 23]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2010/11/WC500099359.pdf
   Google Scholar
• Committee for Medicinal Products for Human Use (CHMP). Guideline on the investigation of medicinal products in the term and preterm neonate. European Medicines Agency (EMA). 2007. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003754.pdf
   Google Scholar
• Committee for Medicinal Products for Human Use (CHMP), Comm. Discussion paper on the impact of renal immaturity when investigating medicinal products intended for paediatric use. European Medicines Agency (EMA). 2004. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003807.pdf
   Google Scholar
• Kalhan SC, Wilson-Costello D. Prematurity and programming: contribution of neonatal Intensive Care Unit interventions. J Dev Orig Health Dis. 2013 Apr;4(2):121–133.
   PubMed Web of Science ®Google Scholar
• Ciccone MM, Cortese F, Gesualdo M, et al. The role of very low birth weight and prematurity on cardiovascular disease risk and on kidney development in children: a pilot study. Minerva Pediatr. 2016 Jun 29. PMID:27355157.
   PubMedGoogle Scholar
• Starzec K, Klimek M, Grudzien A, et al. Longitudinal assessment of renal size and function in extremely low birth weight children at 7 and 11 years of age. Pediatr Nephrol. 2016 May 27;31:2119–2126.
   PubMed Web of Science ®Google Scholar
• Galu SC, Hascoet JM, Vieux R. Impact of neonatal factors and nutrition on kidney size in 5-year-old preterm-born children. Am J Perinatol. 2015 Feb;32(3):219–224.
   PubMed Web of Science ®Google Scholar
• Bueters RR, van de Kar NC, Schreuder MF. Adult renal size is not a suitable marker for nephron numbers: an individual patient data meta-analysis. Kidney Blood Press Res. 2013;37(6):540–546.
   PubMed Web of Science ®Google Scholar
• Bennett KM, Bertram JF, Beeman SC, et al. The emerging role of MRI in quantitative renal glomerular morphology. Am J Physiol Renal Physiol. 2013 May 15;304(10):F1252–F1257.
   PubMed Web of Science ®Google Scholar
• Wei FF, Zhang ZY, Petit T, et al. Retinal microvascular diameter, a hypertension-related trait, in ECG-gated vs. non-gated images analyzed by IVAN and SIVA. Hypertens Res. 2016 Jul 7;39:886–892.
   PubMed Web of Science ®Google Scholar
• Newman AR, Andrew NH, Casson RJ. Review of paediatric retinal microvascular changes as a predictor of cardiovascular disease. Clin Exp Ophthalmol. 2017 Jan;45(1):33–44.
   PubMed Web of Science ®Google Scholar
• Mitchell P, Cheung N, de HK, et al. Blood pressure and retinal arteriolar narrowing in children. Hypertension. 2007 May;49(5):1156–1162.
   PubMed Web of Science ®Google Scholar
• Raaijmakers A, Petit T, Gu Y, et al. Design and feasibility of “PREMATurity as predictor of children’s Cardiovascular-renal Health” (PREMATCH): A pilot study. Blood Press. 2015;24(5):275–283.
   PubMed Web of Science ®Google Scholar
• Gishti O, Jaddoe VW, Felix JF, et al. Impact of maternal smoking during pregnancy on microvasculature in childhood. The Generation R Study. Early Hum Dev. 2015 Oct;91(10):607–611.
   PubMed Web of Science ®Google Scholar
• Tryggvason K, Patrakka J, Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med. 2006 Mar 30;354(13):1387–1401.
   PubMed Web of Science ®Google Scholar
• Mathieson PW. The podocyte as a target for therapies – new and old. Nat Rev Nephrol. 2012 Jan;8(1):52–56.
   Web of Science ®Google Scholar
• Sun D, Zhao X, Meng L. Relationship between urinary podocytes and kidney diseases. Ren Fail. 2012;34(3):403–407.
   PubMed Web of Science ®Google Scholar
• Lavery AP, Meinzen-Derr JK, Anderson E, et al. Urinary NGAL in premature infants. Pediatr Res. 2008 Oct;64(4):423–428.
   PubMed Web of Science ®Google Scholar
• Trof RJ, Di MF, Leemreis J, et al. Biomarkers of acute renal injury and renal failure. Shock. 2006 Sep;26(3):245–253.
   PubMed Web of Science ®Google Scholar
• Chen CN, Chou CH, Jeng SF, et al. Urinary neutrophil gelatinase-associated lipocalin levels in neonates. Pediatr Neonatol. 2016 Jun;57(3):207–212.
   PubMed Web of Science ®Google Scholar
• DeFreitas MJ, Seeherunvong W, Katsoufis CP, et al. Longitudinal patterns of urine biomarkers in infants across gestational ages. Pediatr Nephrol. 2016 Jul;31(7):1179–1188.
   PubMed Web of Science ®Google Scholar
• Huynh TK, Bateman DA, Parravicini E, et al. Reference values of urinary neutrophil gelatinase-associated lipocalin in very low birth weight infants. Pediatr Res. 2009 Nov;66(5):528–532.
   PubMed Web of Science ®Google Scholar
• Bolignano D, Donato V, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis. 2008 Sep;52(3):595–605.
   PubMed Web of Science ®Google Scholar